WallStreetZenWallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel Patrick OdayChairman CEO2026-02-05115,640$150.00
$17.35MSell
Daniel Patrick OdayChairman CEO2026-02-05115,640$66.01
$7.63MBuy
Andrew D. DickinsonChief Financial Officer2026-02-0324,802$143.28
$3.55MSell
Johanna MercierChief Comm Corp Aff Officer2026-02-0324,800$143.28
$3.55MSell
Daniel Patrick OdayChairman CEO2026-02-0374,461$143.28
$10.67MSell
Daniel Patrick OdayChairman CEO2026-01-285,032$139.54
$702.19kSell
Daniel Patrick OdayChairman CEO2026-01-284,968$140.24
$696.73kSell
Daniel Patrick OdayChairman CEO2026-01-23115,640$66.01
$7.63MBuy
Daniel Patrick OdayChairman CEO2026-01-23115,640$135.00
$15.61MSell
Jeffrey BluestoneDirector2026-01-205,000$67.45
$337.25kBuy

1 of 11

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.93%123,195,578$19.09BInstitution
Vanguard Group Inc9.76%121,097,336$18.77BInstitution
State Street Corp4.86%60,240,518$9.34BInstitution
Capital World Investors3.46%42,872,129$6.64BInstitution
Geode Capital Management LLC2.39%29,696,002$4.60BInstitution
Dodge Cox2.12%26,283,511$4.07BInstitution
Capital Research Global Investors2.04%25,307,071$3.92BInstitution
Morgan Stanley1.90%23,512,734$3.64BInstitution
Jpmorgan Chase Co1.86%23,035,763$3.57BInstitution
Norges Bank1.72%21,322,732$3.30BInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD66.92%1.11%Net SellingNet Selling
AMGN70.10%0.99%Net SellingNet Selling
PFE55.18%0.27%Net BuyingNet Selling
BMY65.73%0.37%Net SellingNet Selling
GSK6.52%0.00%
View Top General Drug Manufacturer Stocks

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 66.92% institutional shareholders, 1.11% Gilead Sciences insiders, and 31.97% retail investors. Blackrock Inc is the largest individual Gilead Sciences shareholder, owning 123.20M shares representing 9.93% of the company. Blackrock Inc's Gilead Sciences shares are currently valued at $19.09B.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.